期刊文献+

地区性肌酸激酶及乳酸脱氢酶检测标准化途径设计与实施 被引量:1

The design and implementation of regional creatine kinase/lactate dehydrogenase detectionstandardization
原文传递
导出
摘要 目的基于嘉兴市临床实验室现状设计适合此地区的肌酸激酶(CK)/乳酸脱氢酶(LDH)检测的标准化方案并实施,以减小检测结果的室问变异,保证检测结果的正确性及溯源性。方法基于临床检验结果溯源性要求,于2012年10月至2013年2月期间,在嘉兴市6家医院,以国家一级标准物质GBW09167、GBW09168以及新鲜血清作为样本在嘉兴33家医院的临床实验室进行正确度验证以及室内不精密度调查;筛取其中6家室内不精密度(CV)小于2%的实验室,以血清基质标准物质GBW(E)091361作为校准品,GBW(E)091360作为正确度质量控制品,比较实施标准化前后检测结果的差异。结果33家实验室中,31家实验室室内CV小于2%,肌酸激酶偏移为-7%~12%,乳酸脱氢酶偏移为-22%~15%。6家CV小于2%的实验室,标准化实施过程中,具统计意义的5家实验室血清样本检测结果如下:肌酸激酶室间变异由校准前的4.95%~6.55%降低到校准后的1.81%~2.33%,乳酸脱氢酶则由5.75%~11.68%降低到1.39%~1.80%;肌酸激酶的偏倚由校准前的-0.84%~6.23%降到-0.15%~2.44%;乳酸脱氢酶的偏倚由-10.18%-0.34%降低到校准后的-3.07%~0.58%。结论基于实验室全面质量管理,以统一的校准方案,统一的具有互通性的标准物质作为校准品,可降低不同实验室室问检测结果的差异,提高检测准确性。(中华检验医学杂志,2014.37:947-950) Objective To design and implement the standardization scheme of creatine kinase (CK)/lactate dehydrogenase (LDH) detection based on the present situation of clinical laboratory in Jiaxing, and attempt to reduce the imprecision and bias of the results in different clinical laboratories, obtain the traceable results. Methods According to the requirements of traceability in clinical laboratory, the CK/ LDH standardization scheme was explored in Jiaxing from 2012, October to 2013, February, CK/LDH national reference material GBW09167, GBW09168 and serum pool were as samples for aeeuraey verification and impression in 33 local hospitals; then the reference materials GBW(E) 03061 was as calibrator, while the GBWE03060 was performed as calibration verification material during the tests, the SOP for calibration made by the clinical quality control center was operated in calibration; as a result a scientific, practical standard scheme was developed. Results The equipment of clinical labrotories in Jiaxing are all imported, the laboratory management is well. However the bias of CK is - 7% -12% and the bias of LDH is above -22%-15%. And then the standardization scheme was implemented in 6 Laboratories in which CV was lessthan 2% , and high-quality data of 5 laboratories are as follows : imprecision of CK and LDH in different labs were reduced from 4. 95% -6. 55% to 1.81% -2.33% and 5.75% -11.68% to 1.59% -1.80% individually, bias for CK is reduced from -0. 84 %-6. 23% to -0. 15%-2.44% ; while in lactate dehydrogenase test, the bias is decreased from - 10. 18% 4). 34% to - 3.07% 4). 58% . Conclusion Using the commutable and traceable reference material as calibrator, strengening the laboratory management such as nmking a calibration SOP will be a effective methods to realize the standardization in measurement. ( Chin J Lab Med, 2014,37 : 947-950 )
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2014年第12期947-950,共4页 Chinese Journal of Laboratory Medicine
基金 浙江省重点科技创新团队项目(2012R10019) 浙江省重大科技专项重大社会发展项目(2012C3007-4) 国家质检总局公益性行业科研专项经费项目(20120066)
关键词 肌酸激酶 乳酸脱氢酶类 参考标准 实验室 医院 研究设计 Creatine kinase Lactate dehydrogenases Reference standards Laboratories,hospital Research design
  • 相关文献

参考文献9

  • 1卫生部办公厅.卫生部办公厅关于医疗机构间医学检验、医学影响检查有关问题的通知.卫办医发[2006]32号,2006.2.28.
  • 2Greg Miller W, Myers GL, Lou Gantzer M harmonization of clinical laboratory Clin Chem, 2011, 57:1108-1117.
  • 3t procedures [ J ] Jansen RT, Kenny D, Blaton V, et al. Usefulness of" EC4 essential criteria for quality systems of medical laboratories as guideline to the ISO 15189 and ISO 17025 documents. European Community Confederation of Clinical Chemistry (EC4) Working Group on Harmonisation of Quality Systems and Aeereditation[ J]. Clin Chem Lab Med, 2000, 38 : 1057-1064.
  • 4Sciacovelli L, Zardo L, Seeehiero S, et al. Qnality specifications in EQA schemes: from theory to practiee[ J 1. Clin Chim Acta, 2004, 346:87-97.
  • 5Cattozzo G, Franzini C, Melzi d' Eril GM. Cmnmutability of ealibration and control materials for serum lipase [ J ]. Clin Chem, 2001,47:2108-2113.
  • 6Miller WG, Myers GL, Ashwood ER, et al. Creatinine measurement: state of the art in aeeuracy and interlaboratory harmonization[J]. Arch Pathol Lab Med, 2005, 129:297-304.
  • 7Klee GG. Harmonization and standardization of' thyroid function tests[J]. Clin Chem, 2010, 56:879-880.
  • 8中华人民共和国卫生行业标准.WS/T403-2012临床生物化学检验常规项目分析质量指标.2012年.
  • 9周杰英,曹友德.ISO15189在医学实验室管理中的运用[J].国际检验医学杂志,2013,34(2):247-249. 被引量:26

二级参考文献13

  • 1丛玉隆,邓新立.实验室ISO15189认可对学科建设的几点启示[J].中华检验医学杂志,2007,30(2):128-131. 被引量:121
  • 2中国合格评定国家认可委员会.CNAS-CL02:2007医学实验室质量和能力认可准则(ISO15189:2007)[S].北京:中国计量出版社,2008:1-36.
  • 3中华人民共和国国家质量监督检验检疫局,中国国家标准化管理委员会.GB1948-2004实验室生物安全通用要求[S].北京:中华人民共和国国家质量监督检验检疫局,2004.
  • 4Hawkins R. Managing the pre-and post-analytical phases of thetotal testing process[J]. Ann Lab Med,2012,32(1) :5-16.
  • 5Chen B,Gagnon M,Shahangian S,et al. Good laboratory practicesfor molecular genetic testing for heritable diseases and conditions[J]. MMWR Recomm Rep,2009 ,58(6) : 1-37.
  • 6Sikaris K. Analytical quality-What should we be aiming for[J].Clin Biochem,2008,29(1) :5-10.
  • 7Shott JP,Galiwango RM,Reynolds SJ. A quality management ap-proach to implementing point-of-care technologies for HIV diag-nosis and monitoring in Sub-Saharan Africa[J/OL]. J Trop Med,2012-01-11 [ 2012-11-12 ],http://www. ncbi. nlm. nih. gov/pubmed/22287974.
  • 8Barlow-Stewart K,Burnett L. Ethical considerations in the use ofDNA for the diagnosis of diseases[J]. Clin Biochem,2006,27(1):53-61.
  • 9Zeh CE,Inzaule SC, Magero VO, et al. Field experience in imple-menting IS015189 in Kisumu,Kenya[J]. Am J Clin Pathol,2010,134(3):410-418.
  • 10杨有业,梁锦胜,杨志钊,陈桂山,陈满章,温冬梅,蔡常辉.ISO15189在检验科管理中的应用[J].基础医学与临床,2008,28(1):84-86. 被引量:13

共引文献25

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部